Literature DB >> 12817894

Gabapentin blocks L-type and P/Q-type Ca2+ channels involved in depolarization-stimulated nitric oxide synthase activity in primary cultures of neurons from mouse cerebral cortex.

Michiko Oka1, Yoshinori Itoh, Miyuki Wada, Akira Yamamoto, Takuya Fujita.   

Abstract

PURPOSE: The effect of gabapentin [1-(aminomethyl)cyclohexane acetic acid] on Ca2+ channels involving the activation of nitric oxide synthase (NOS) was investigated in primary neuronal culture of mouse cerebral cortex.
METHODS: The expression of alpha2delta subunits of Ca2+ channels was investigated by RT-PCR using specific primer sets. The K(+)-evoked NOS activity was estimated by guanosine 3'5' cyclic monophosphate (cGMP) formation.
RESULTS: mRNA for alpha2delta subunits of Ca2+ channels is found in these cells. Gabapentin blocked the K(+)-evoked NOS activity estimated from cGMP formation in a concentration dependent manner. The increase in NOS activity by the K(+)-stimulation was almost completely reversed by the combination of nifedipine, an L-type Ca2+ channel blocker, and omega-agatoxin VIA, a P/Q-type Ca2+ channel blocker. On the other hand, omega-conotoxin GVIA, an N-type Ca2+ channel blocker, was failed to reverse the increase in NOS activity by the K(+)-stimulation, indicating that the activation of NOS by the depolarizing stimulation might be not mediated by N-type Ca2+ channel. Under the presence of nifedipine or omega-agatoxin IVA, gabapentin inhibited the increase in NOS activity concentration-dependently.
CONCLUSIONS: These results suggest that gabapentin inhibits depolarization-induced NOS activation in murine cortical neuronal culture via blockade of both P/Q-type and L-type Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12817894     DOI: 10.1023/a:1024078704020

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Antinociceptive effects of Ca2+ channel blockers.

Authors:  H F Miranda; D Bustamante; V Kramer; T Pelissier; H Saavedra; C Paeile; E Fernandez; G Pinardi
Journal:  Eur J Pharmacol       Date:  1992-07-07       Impact factor: 4.432

2.  Blockade by NS-7, a neuroprotective compound, of both L-type and P/Q-type Ca2+ channels involving depolarization-stimulated nitric oxide synthase activity in primary neuronal culture.

Authors:  M Oka; Y Itoh; Y Ukai; K Kimura
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

3.  Structural requirement of the calcium-channel subunit alpha2delta for gabapentin binding.

Authors:  M Wang; J Offord; D L Oxender; T Z Su
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

4.  Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain.

Authors:  A Caraceni; E Zecca; C Martini; F De Conno
Journal:  J Pain Symptom Manage       Date:  1999-06       Impact factor: 3.612

5.  Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones.

Authors:  K G Sutton; D J Martin; R D Pinnock; K Lee; R H Scott
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Involvement of Na+ and Ca2+ channel activation and resultant nitric oxide synthesis in glutamate-mediated hypoxic injury in rat cerebrocortical slices.

Authors:  M Oka; Y Itoh; Y Ukai
Journal:  Life Sci       Date:  2000-09-29       Impact factor: 5.037

7.  Modulation of K(+)-induced synaptosomal calcium influx by gabapentin.

Authors:  W P Meder; D J Dooley
Journal:  Brain Res       Date:  2000-09-01       Impact factor: 3.252

8.  Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices.

Authors:  K Fink; W Meder; D J Dooley; M Göthert
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

9.  The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel.

Authors:  N S Gee; J P Brown; V U Dissanayake; J Offord; R Thurlow; G N Woodruff
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

Review 10.  Clinical efficacy and safety of gabapentin.

Authors:  R E Ramsay
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

View more
  3 in total

Review 1.  P/Q-type calcium channel modulators.

Authors:  V Nimmrich; G Gross
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  Involvement of NO/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test.

Authors:  Sattar Ostadhadi; Nastaran Kordjazy; Arya Haj-Mirzaian; Sanaz Ameli; Golnoosh Akhlaghipour; AhmadReza Dehpour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-12       Impact factor: 3.000

3.  Comparing the prophylactic effects of oral gabapentin, pregabalin, and celecoxib on postoperative pain management in orthopedic surgery of the lower extremity: A double-blind randomized controlled trial.

Authors:  Dorna Kheirabadi; Mohammad Reza Safavi; Marzieh Taghvaei; Mohammad Reza Habibzadeh; Azim Honarmand
Journal:  J Res Med Sci       Date:  2020-01-20       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.